Skip to main content

Table 1 Summary of results

From: Changes in specialized blood vessels in lymph nodes and their role in cancer metastasis

HEV parameters Clinical data Relative risk p 95% Confidence interval
Total no. of HEV (A) Overall Survival 1.024 0.471 0.961 ~ 1.091
  Disease Free Interval 1.051 0.022 1.007 ~ 1.097
Total no. of HEV (A) and Disease Free Interval (as a Cohort) Disease Free Interval 1.051 0.023 1.007 ~ 1.096
Dilated HEV (B) Overall Survival 1.071 0.476 0.886 ~ 1.295
  Disease Free Interval 1.034 0.594 0.915 ~ 1.169
HEV with RBC within its lumen (C) Overall Survival 1.116 0.345 0.889 ~ 1.401
  Disease Free Interval 1.044 0.584 0.896 ~ 1.216
Ratio of dilated HEVs to the total no. of HEV(B/A) Overall Survival 1.078 0.982 0.002 ~ 638.23
  Disease Free Interval 10.10 0.450 0.001 ~ 39.89
Ratio of dilated HEVs with RBC to total no. HEV (C/A) Overall Survival 3.624 0.737 0.002 ~ 6634.42
  Disease Free Interval 4.67 0.643 0.001 ~ 145.83
Ratio of dilated HEVs with RBC within its lumen to total no. of dilated HEV (C/B) Overall Survival 17.884 0.171 0.287 ~ 1114.67
  Disease Free Interval 5.458 0.208 0.389 ~ 76.616